Previcox

国: ニュージーランド

言語: 英語

ソース: Ministry for Primary Industries

即購入

ダウンロード 製品の特徴 (SPC)
01-01-2023
ダウンロード 公開評価報告書 (PAR)
01-06-2018

有効成分:

firocoxib

から入手可能:

Boehringer Ingelheim Animal Health New Zealand Limited

INN(国際名):

firocoxib

構図:

firocoxib 240 g/kg

治療領域:

Analgesic

認証ステータス:

ACVM Registered

承認日:

2005-01-31

製品の特徴

                                Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 1 of 14
BOTTLE LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS
FOR ANIMAL TREATMENT ONLY
PREVICOX
®
57 MG HI-SELECT COX-2 FLAVOURED TABLETS: PAIN & INFLAMMATION CONTROL
FOR DOGS
EACH TABLET CONTAINS 57 MG FIROCOXIB
A highly selective COX-2 inhibitor for relief of pain and control of
inflammation associated with
osteoarthritis and other musculo-skeletal disorders. PREVICOX is also
indicated for the control of post-
operative pain associated with surgery; including soft tissue,
orthopaedic and dental procedures.
57 mg
60 tablets
_(BI logo) _
_ _
READ THE LEAFLET FOR FULL INSTRUCTIONS.
Store below 30 °C (Room temperature)
APVMA No: 58093/126349
New Zealand Info: RVM
ACVM No: A009342
Made in France.
[B]:
[E]:
Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 2 of 14
CARTON (BOTTLE) LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS
FOR ANIMAL TREATMENT ONLY
PREVICOX
®
57 MG HI-SELECT COX-2 FLAVOURED TABLETS: PAIN & INFLAMMATION CONTROL
FOR DOGS
EACH TABLET CONTAINS 57 MG FIROCOX
IB
57 mg
60 tablets
_(BI logo) _
Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 3 of 14
_ _
_ _
_ _
A highly selective COX-2 inhibitor* for relief of pain and control of
inflammation associated with
osteoarthritis and other musculo-skeletal disorders. PREVICOX is also
indicated for the control of post-
operative pain associated with surgery; including soft tissue,
orthopaedic and dental procedures.
*At least 350X selection of COX-2 over COX-1 in _in vitro _canine
blood assays. No COX-1 inhibition _in vitro _at levels observed in
plasma after
therapeutic doses.
READ THE LEAFLET FOR FULL INSTRUCTIONS.
DIRECTIONS FOR USE
CONTRAINDICATIONS
This product should not be used in cats as a dose level for firocoxib
has not been established. This
product should not be used in any dog that has previously exhibited
hypersensitivity to firocoxib.
DOSAGE AND ADMINISTRATION
FOR ORAL
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索

ドキュメントの履歴を表示する